Liposomal Doxorubicin for Treatment of Metastatic Chemorefractory Vulvar Adenocarcinoma
Huang GS, Juretzka M, Ciaravino G, Kohler S, Teng NN. Liposomal Doxorubicin for Treatment of Metastatic Chemorefractory Vulvar Adenocarcinoma. Gynecologic Oncology 2002, 87: 313-318. PMID: 12468332, DOI: 10.1006/gyno.2002.6830.Peer-Reviewed Original ResearchConceptsVulvar adenocarcinomaLiposomal doxorubicinPelvic lymph node dissectionGroin lymph nodesLymph node dissectionExtramammary Paget's diseaseYears of survivalWarrants further investigationBulky involvementGroin irradiationInitial therapyNode dissectionMultiagent chemotherapyRadical vulvectomyGynecologic malignanciesMetastatic diseaseLymph nodesInitial diagnosisMetastatic lesionsPaget's diseaseDramatic regressionRare entityDoxil treatmentEffective treatmentSubcutaneous lesions